EZH2 and oral cavity squamous cell carcinoma: For example, Hong et al. illustrated that lncRNA H19 promotes cell proliferation and invasion by acting as a competing endogenous RNA of miR-138 and releasing EZH2 in oral squamous cell carcinoma, and suggest that H19 may represent a potential therapeutic target for oral squamous cell carcinoma [9].